Blow-Fill-Seal technology and vaccine del...Unit-dose?The SARS-CoV2 pandemic caused 6.3 million deaths and contaminated 545 million people across the world. In spite of the rapid development and approval of vaccines, the shortages of consumables … more ➔
Making a better cheeseThe French company Standing Ovation uses precision fermentation to create the protein that gives cheese its unique properties. With his pitch, co-founder and CEO Frédéric P’ques took the prize at the … more ➔
AGC Biologics doubles mammalian capacityWith a new expansion coming online in Copenhagen, AGC Biologics is offering more capacity in Europe for mammalian biologics projects using innovative single-use bioreactor technology. This is the latest … more ➔
Unleashing the power of LNP encapsulationThe Covid-19 pandemic has changed perception of the value of rapid vaccine production, followed by multi-billion investments across the globe. While nanomedicines are receiving attention for enhancing … more ➔
Cells: The heart of Biovians rAAV manufa...Viral Vectors?Commercial-scale manufacturing demands a high yield of potent rAAV products. Understanding the metabolism during cell growth, especially at high densities, molecular effects of transfection … more ➔
Vector BioPharma: the future of gene deliv...Precision gene delivery remains one of the greatest challenges in modern medicine. A Basel-based biopharma company, Vector BioPharma, has accepted the challenge and, with cutting-edge technology from … more ➔
Crossing the commercialisation chasmAs a late-stage investor focusing on the European bioeconomy, the ECBF is carefully assessing the maturity of any technology, but more important than maturity is the ability to reach commercial scale. … more ➔
CDMOCDMO excellence in phytocannabinoid produc...CB21 Pharma Ltd announces that it entered a global strategic collaboration to combineits leading expertise and clinical research program in phytocannabinoids with world-classpharmaceutical strategic … more ➔
Sourcing innovation in the Life Sciences s...BioFIT is Europes leading partnering event in Life Sciences for tech transfer, early-stage innovation deals and pre-seed, seed and Series A investment, receiving each year more than 1,000 delegates … more ➔
Pulsating biotech locationTakeda, Boehringer Ingelheim and Novartis do it repeatedly. Global players make major investments in their Austrian facilities. Not only multinationals but start-ups and scale-ups such as Apeiron … more ➔
